Skan AG / Schlagwort(e): Börsengang
FOR RELEASE IN SWITZERLAND - THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES.
SKAN gibt vollständige Ausübung der Mehrzuteilungsoption bekannt
Allschwil, 2. November 2021 - Die SKAN Group AG, Weltmarktführerin bei hochwertigen Isolatorsystemen für aseptische Produktionsprozesse in der (bio-)pharmazeutischen Industrie, hat heute bekannt gegeben, dass die Joint Global Coordinators die ihnen im Rahmen des Börsengangs gewährte Mehrzuteilungsoption zum Angebotspreis von CHF 54 je Aktie vollständig ausgeübt haben.
Die Aktien der SKAN Group AG sind am 28. Oktober 2021 zum Handel an der SIX Swiss Exchange zugelassen worden. Heute haben die Joint Global Coordinators Credit Suisse und Berenberg die Mehrzuteilungsoption zum Kauf von 500'000 bestehenden Aktien zu CHF 54 je Aktie vollständig ausgeübt.
Einschliesslich der Aktien aus der Mehrzuteilungsoption wurden beim IPO 5'000'000 Aktien platziert, davon 1'731'494 neue und 3'268'506 bestehende Aktien. Das Platzierungsvolumen beläuft sich auf insgesamt CHF 270 Mio. Nach Ausübung der Mehrzuteilungsoption beträgt der Streubesitz (Free Float) rund 50 Prozent - inklusive des Anteils der pre-IPO-Aktionäre, die nach Abschluss des Angebots eine Beteiligung von weniger als 3 Prozent halten.
Thomas Balmer, Dynamics Group AG, firstname.lastname@example.org, +41 79 703 87 28
1968 gegründet, zählt SKAN zu den Pionierfirmen in den Fachbereichen Reinraumausrüstungen und Bau von Isolatoren für die pharmazeutische Industrie. Innovative Produkte, kundenspezifische Lösungen sowie eine leistungsfähige Dienstleistungs- und Serviceorganisation haben SKAN zu einem Marktführer und wichtigen Partner der Industrie und Forschungslaboratorien werden lassen.
Statements made in this publication may include forward-looking statements. These statements may be identified by the fact that they use words such as "anticipate", "estimate", "should", "expect", "guidance", "project", "intend", "plan", "believe", "will", "could" and/or other words and terms of similar meaning in connection with, among other things, any discussion of results of operations, financial condition, liquidity, prospects, growth, strategies or developments in the industry in which we operate. Such statements are based on management's current intentions, expectations or beliefs and involve inherent risks, assumptions and uncertainties, including factors that could delay, divert or change any of them. Forward-looking statements contained in this media release regarding trends or current activities should not be taken as a representation that such trends or activities will continue in the future. Actual outcomes, results and other future events may differ materially from those expressed or implied by the statements contained herein. Such differences may adversely affect the outcome and financial effects of the plans and events described herein and may result from, among other things, changes in economic, business, competitive, technological, strategic or regulatory factors and other factors affecting the business and operations of the company. Neither SKAN Group AG nor SKAN Holding AG nor any of their respective affiliates is under any obligation, and each such entity expressly disclaims any such obligation, to update, revise or amend any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on any such forward-looking statements, which speak only as of the date of this media release. It should be noted that past performance is not a guide to future performance.
Except as required by applicable law, SKAN Group AG has no intention or obligation to update, keep updated or revise this publication or any parts thereof (including any forward looking statement) following the date hereof.
This announcement is not for distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any state of the United States and the District of Columbia), Canada, Japan, Australia or any jurisdiction into which the same would be unlawful. This announcement does not constitute or form a part of any offer or solicitation to purchase, subscribe for or otherwise acquire securities in the United States, Canada, Japan, Australia or any jurisdiction in which such an offer or solicitation is unlawful. SKAN Group AG shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States.
The information contained herein does not constitute an offer of securities to the public in the United Kingdom, and no such offer of securities to will be made to the public in the United Kingdom, except that offers of securities may be made to the public in the United Kingdom at any time under the following exemptions under the UK Prospectus Regulation: (i) to any legal entity which is a qualified investor as defined in Article 2 of the UK Prospectus Regulation; or (ii) in any other circumstances falling within section 86 of the Financial Services and Markets Act 2000 (the "FSMA"), provided that no such offer of securities shall require SKAN Group AG to publish a prospectus pursuant to section 85 of the FSMA or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation. For the purposes of this provision, the expression an "offer to the public" in relation to the securities means the communication in any form and by any means of sufficient information on the terms of the offer and the securities to be offered so as to enable an investor to decide to purchase the securities, and the expression "UK Prospectus Regulation" means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. In addition, in the United Kingdom, this document is only being distributed to and is only directed at (i) investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"), (ii) high net worth entities falling within article 49 of the Order or (iii) other persons to whom it may lawfully be communicated, (all such persons together being referred to as "relevant persons"). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.
In relation to each member state of the European Economic Area (each a "Member State"), no securities have been offered and will be offered to the public in that Member State, except that offers of securities may be made to the public in that Member State at any time under the following exemptions under the Prospectus Regulation: (i) to any legal entity which is a qualified investor as defined under the Prospectus Regulation; or (ii) in any other circumstances falling within Article 1(4) of the Prospectus Regulation, provided that no such offer of securities shall require SKAN Group AG to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. For the purposes of this provision, the expression an "offer to the public" in relation to the securities in any Member State means the communication in any form and by any means of sufficient information on the terms of the offer and any securities to be offered so as to enable an investor to decide to purchase securities, and the expression "Prospectus Regulation" means Regulation (EU) 2017/1129.
Information to Distributors: Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Shares have been subject to a product approval process by each Manager established in the EEA, which has determined that the Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, distributors should note that: the price of the Shares may decline and investors could lose all or part of their investment; the Shares offer no guaranteed income and no capital protection; and an investment in the Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom.
The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the offering. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Managers established in the EEA will only procure investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Shares. Each distributor is responsible for undertaking its own target market assessment in respect of the Shares and determining appropriate distribution channels.
None of the underwriters or any of their respective subsidiary undertakings, accepts any responsibility or liability whatsoever for, or makes any representation, warranty or undertaking, express or implied, as to the truth, accuracy, completeness or fairness of the information or opinions in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the group, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith. Accordingly, each of the underwriters and the other foregoing persons disclaim, to the fullest extent permitted by applicable law, all and any liability, whether arising in tort or contract or that they might otherwise be found to have in respect of this announcement and/or any such statement.
Ende der Ad-hoc-Mitteilung
SIX Swiss Exchange
EQS News ID:
Ende der Mitteilung
EQS Group News-Service